Locate the conus terminus (~L1–L2), target L3–L4 or L4–L5; identify Tuffier's intercristal line at L4.
State accepted indications; apply Hasbun pre-LP CT rule; recite platelet, INR, and LMWH thresholds.
Position, prep, midline insertion with bevel parallel to dural fibers; stylet replaced before withdrawal.
Connect manometer, measure in lateral decubitus with legs extended; recognize seated reading as invalid.
Collect tubes 1→4 with appropriate volumes; interpret tube-1 vs tube-4 RBC for traumatic-tap discrimination.
Lead dual-practitioner verification of agent, dose, route; escalate complications per UCI policy.
CSF cell count, Gram stain, culture, glucose, protein, viral PCR. Empiric antibiotics in parallel — never delayed for CT or LP per IDSA Tunkel 2017.
Beyond the early high-sensitivity CT window — xanthochromia by spectrophotometry at ≥12 h after symptom onset is the late-window CSF signal per Edlow 2000.
Idiopathic intracranial hypertension diagnosis (Friedman 2013); normal-pressure hydrocephalus workup; high-pressure headache evaluation.
Oligoclonal bands, IgG index, paraneoplastic and autoimmune panels, cytology in suspected leptomeningeal disease.
Cytology and flow cytometry for leptomeningeal involvement — per UCI canonical post-test Q1 indication list.
Chemotherapy (methotrexate, cytarabine), intrathecal antibiotics, spinal anesthesia — dual-practitioner verification required.
When meningitis is suspected, empiric coverage goes in as soon as blood cultures are drawn — imaging delay is not a reason to delay antibiotics. The LP itself is what waits on the CT.
Withdrawing the needle halfway and re-advancing risks losing subarachnoid position and increases traumatic-tap rate on the next pass. Coughing is not a standard maneuver either.
| Tube | Test |
|---|---|
| 1 | Cell count + differential |
| 2 | Glucose, protein, chemistry |
| 3 | Gram stain + culture |
| 4 | Cell count + differential (vs tube 1) · reserved volume for cytology, OCBs, viral PCR |
Positional, worse upright. Conservative: hydration, analgesia, caffeine 300–500 mg PO. Blood patch if refractory beyond 48–72 h (post-test Q11).
Local soft-tissue trauma. Self-limited. NSAIDs or acetaminophen.
Diagnostic ambiguity. Tube 1 vs Tube 4 RBC clearing argues against true SAH (post-test Q13).
Transient nerve-root irritation. Withdraw and redirect. Persistent radiculopathy → escalate.
Meningitis or local site infection. Rare with chlorhexidine prep and sterile technique. Reportable event.
Coagulopathy or LMWH-bridged patients. Acute back pain + neurologic deficit = MRI + neurosurgery emergency.
Elevated ICP with mass effect missed pre-LP. Prevention is the Hasbun rule — there is no rescue once herniation begins.
Indeterminate CSF — repeat at a different interspace, image-guidance, or hematology / oncology consult.
| Stage | Trigger | Scope |
|---|---|---|
| FPPE | Board approval of LP privilege | First 5 independent LPs · per-case review within 14 days · aggregate at 5 cases |
| OPPE | Continuous baseline | Every 6 mo · 10% sample (min 2, max 10) · 100% review on severe complication |
| Lapse | < 3 LPs in 24 mo | Stream C simulation + 2 proctored cases before independent practice resumes |